Literature DB >> 6633671

Effects of clonidine on the rate of noradrenaline turnover in discrete areas of the rat central nervous system.

H P Lorez, D Kiss, M Da Prada, G Haeusler.   

Abstract

Turnover of noradrenaline in various regions of the rat brain was estimated by the decrease in noradrenaline content and/or formaldehyde-induced catecholamine fluorescence after inhibition of noradrenaline biosynthesis with alpha-methyl-p-tyrosine. Clonidine (0.1 and 0.3 mg/kg p.o.) decelerated the decrease in noradrenaline content of the locus coeruleus, the nucleus of the solitary tract, the intermediolateral cell column and the ventral horn of the thoracic spinal cord, as measured in tissue punches of the respective regions with a sensitive radioenzymatic method. In all these central regions the clonidine-induced decrease in noradrenaline turnover was antagonized by yohimbine, but not by phenoxybenzamine, indicating mediation through central alpha 2-adrenoceptors, similar to the cardiovascular effects of clonidine. When given alone, both yohimbine and phenoxybenzamine accelerated the disappearance of noradrenaline after inhibition of its biosynthesis. The combined results of radioenzymatic assay and fluorescence histochemistry determinations demonstrated that clonidine markedly reduced noradrenaline turnover in central noradrenaline-containing nerve terminals, but had no effect on the cell bodies of the A1 and A2 cell groups. Noradrenaline turnover was, however, decreased in projection areas of the A1 and A2 cell groups, namely the intermediolateral cell column of the spinal cord and nucleus of the solitary tract, respectively. This observation argues against the existence of a neuronal feedback loop running from the projection areas to the cell bodies of the A1 and A2 cell groups and mediating inhibition of noradrenaline turnover. The effect of clonidine on noradrenaline turnover is, therefore, most likely the result of a local feedback inhibition through presynaptic alpha-adrenoceptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6633671     DOI: 10.1007/BF00512468

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. II. EXPERIMENTALLY INDUCED CHANGES IN THE INTRANEURONAL AMINE LEVELS OF BULBOSPINAL NEURON SYSTEMS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

2.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

Authors:  K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

3.  Reduced hypotensive effect of clonidine after lesions of the nucleus tractus solitarii in rats.

Authors:  J Lipski; J Przybylski; E Solnicka
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

4.  Sites of action of clonidine: centrally mediated increase in vagal tone, centrally mediated hypotensive and sympatho-inhibitory effects.

Authors:  M Laubie; H Schmitt
Journal:  Prog Brain Res       Date:  1977       Impact factor: 2.453

5.  Neuroanatomy of central cardiovascular control. Nucleus tractus solitarii: afferent and efferent neuronal connections in relation to the baroreceptor reflex arc.

Authors:  M Palkovits; L Záborszky
Journal:  Prog Brain Res       Date:  1977       Impact factor: 2.453

6.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

7.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

Review 8.  Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs.

Authors:  G Haeusler
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

9.  Cardiovascular effects following clonidine microinjection into the nucleus tractus solitarii of the rat.

Authors:  R W Rockhold; R W Caldwell
Journal:  Neuropharmacology       Date:  1980-09       Impact factor: 5.250

10.  Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.

Authors:  H Corrodi; K Fuxe; T Hökfelt
Journal:  Life Sci       Date:  1966-04       Impact factor: 5.037

View more
  6 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

2.  Biochemical evidence that brainstem adrenaline-containing neurons are activated during clonidine withdrawal in the spontaneously hypertensive rat.

Authors:  L Lambás-Señas; J Atkinson; J P Fluckiger; M Sonnay; G Chamba; B Renaud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Food intake and rumen motility in dwarf goats. Effects of atipamezole on the inhibitory effects induced by detomidine, medetomidine and romifidine.

Authors:  A S van Miert; S M Faghihi; C T van Duin
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

4.  Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats.

Authors:  M Ansuategui; L Naharro; M Feria
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.

Authors:  J Sawynok; A Reid
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

6.  Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?

Authors:  D Longrois; F Petitjeans; O Simonet; M de Kock; M Belliveau; C Pichot; Th Lieutaud; M Ghignone; L Quintin
Journal:  Rom J Anaesth Intensive Care       Date:  2021-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.